Iranian Journal of Pharmaceutical Sciences

. R. Vij,R.F. Machado, Pulmonary complications of hemoglobinopathies. Chest, 138 (2010) 973-983.

. N.T. Tran, B. Akkawat, N.P. Morales, P. Rojnuckarin, R. Luechapudiporn, Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition. Platelets, 31 (2020) 505-512.

. P. Joly, C. Pondarre, C. Badens. Beta-thalassemias: molecular, epidemiological, diagnostical and clinical aspects. in Annales de biologie clinique. 2014.

. A.T. Taher,A.N. Saliba, Iron overload in thalassemia: different organs at different rates. Hematology 2014, the American Society of Hematology Education Program Book, 2017 (2017) 265-271.

. L. Iuliano, F. Violi, J.Z. Pedersen, D. Praticò, G. Rotilio, F. Balsano, Free radical-mediated platelet activation by hemoglobin released from red blood cells. Archives of biochemistry and biophysics, 299 (1992) 220-224.

. I. Panigrahi,S. Agarwal, Thromboembolic complications in β-thalassemia: beyond the horizon. Thrombosis research, 120 (2007) 783-789.

. G.J. Kontoghiorghes, Prospects for introducing deferiprone as potent pharmaceutical antioxidant. Frontiers in Bioscience-Elite, 1 (2009) 161-178.

. M. El Alfy, T.T. Sari, C.L. Lee, F. Tricta, A. El-Beshlawy, The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload. Journal of pediatric hematology/oncology, 32 (2010) 601-605.

. S. Venkatesh,R.A. Lipper, Role of the development scientist in compound lead selection and optimization. Journal of pharmaceutical sciences, 89 (2000) 145-154.

. C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced drug delivery reviews, 64 (2012) 4-17.

. L. Di, E.H. Kerns, G.T. Carter, Drug-like property concepts in pharmaceutical design. Current pharmaceutical design, 15 (2009) 2184-2194.

. L. Di, P.V. Fish, T. Mano, Bridging solubility between drug discovery and development. Drug discovery today, 17 (2012) 486-495.

. A. Jouyban, Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. Journal of Pharmacy & Pharmaceutical Sciences, 11 (2008) 32-58.

. M. Abbasi, F. Martinez, A. Jouyban, Prediction of deferiprone solubility in aqueous mixtures of ethylene glycol, propylene glycol and polyethylene glycol 400 at various temperatures. Journal of Molecular Liquids, 197 (2014) 171-175.

. A. Fathi-Azarbayjani, M. Abbasi, J. Vaez-Gharamaleki, A. Jouyban, Measurement and correlation of deferiprone solubility: investigation of solubility parameter and application of van't Hoff equation and Jouyban–Acree model. Journal of Molecular Liquids, 215 (2016) 339-344.

. A. Jouyban, M. Abbasi, E. Rahimpour, M. Barzegar-Jalali, J. Vaez-Gharamaleki, Deferiprone solubility in some non-aqueous mono-solvents at different temperatures: experimental data and thermodynamic modelling. Physics and Chemistry of Liquids, 56 (2018) 619-626.

. C. Zhou, X. Shi, H. Wang, N. An, Measurement and correlation of solubilities of trans-ferulic acid in solvents. JOURNAL OF CHEMICAL INDUSTRY AND ENGINEERING-CHINA-, 58 (2007) 2705.

. H. Buchowski, A. Ksiazczak, S. Pietrzyk, Solvent activity along a saturation line and solubility of hydrogen-bonding solids. The Journal of Physical Chemistry, 84 (1980) 975-979.

. A. Jouyban,W.E. Acree Jr, Mathematical derivation of the Jouyban-Acree model to represent solute solubility data in mixed solvents at various temperatures. Journal of Molecular Liquids, 256 (2018) 541-547.

. A. Jouyban-Gharamaleki, The modified Wilson model and predicting drug solubility in water-cosolvent mixtures. Chemical and pharmaceutical bulletin, 46 (1998) 1058-1061.

. S. Vahdati, A. Shayanfar, J. Hanaee, F. Martínez, W.E. Acree Jr, A. Jouyban, Solubility of carvedilol in ethanol+ propylene glycol mixtures at various temperatures. Industrial & Engineering Chemistry Research, 52 (2013) 16630-16636.

. G.L. Perlovich, S.V. Kurkov, A. Bauer-Brandl, Thermodynamics of solutions: II. Flurbiprofen and diflunisal as models for studying solvation of drug substances. European journal of pharmaceutical sciences, 19 (2003) 423-432.

. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6.

. A. Barton, Expanded cohesion parameters. Chapter 5. Handbook of solubility parameters and other cohesion parameters, (1991).

. R.F. Fedors, A method for estimating both the solubility parameters and molar volumes of liquids. Polymer Engineering & Science, 14 (1974) 147-154.

. Y. Marcus, On the preferential solvation of drugs and PAHs in binary solvent mixtures. Journal of Molecular Liquids, 140 (2008) 61-67.

. A. Jouyban, W.E. Acree Jr, F. Martínez, Modeling the solubility and preferential solvation of gallic acid in cosolvent+ water mixtures. Journal of Molecular Liquids, 224 (2016) 502-506.